Can intermittent, time-restricted circadian fasting modulate cutaneous severity of dermatological disorders? Insights from a multicenter, observational, prospective study.
circadian rhythms and human biological clock
inflammatory dermatoses
intermittent fasting
time-restricted fasting
Journal
Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
revised:
07
02
2021
received:
21
12
2020
accepted:
19
02
2021
pubmed:
26
2
2021
medline:
1
7
2021
entrez:
25
2
2021
Statut:
ppublish
Résumé
The impact of intermittent circadian fasting (ICF) on skin disorders is far to be plenty deciphered. However, the circadian rhythm seems to exert a modulation on dermatoses severity, drug-response, and drug-related side effects. We aimed to evaluate ICF effect in the daily management of dermatological diseases. In this multicenter, prospective observational study we enrolled patients willing to undergo the 2018 ICF (from May 16 to June 14). Dermatoses severity were evaluated at the beginning of ICF (T0) and at the end of ICF (T1) by two independent board-certified dermatologists. Seventy-two patients suffering from different dermatoses volunteered to take part into the study. They displayed a mean age of 40.38 ± 12.46 years (median 41.0 years), 25 subjects were males (34.7% of the entire sample). The median weight change was 0 kg. The overall ICF effect size was -0.58 ([95% CI -0.83 to -0.33], P < .0001, medium effect size). Since in the present investigation no weight loss occurred, we could speculate that the impact of fasting in terms of improvements in the clinical symptoms could be rather due to the perturbation of the human biological clock. Despite our data remain preliminary, a chronobiological approach should be incorporated in the dermatological armamentarium.
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14912Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Harris L, Hamilton S, Azevedo LB, et al. Intermittent fasting interventions for treatment of overweight and obesity in adults: a systematic review and meta-analysis. JBI Database System Rev Implement Rep. 2018;16(2):507-547.
Lessan N, Ali T. Energy metabolism and intermittent fasting: the Ramadan perspective. Nutrients. 2019;11(5):1192.
Ismail S, Manaf RA, Mahmud A. Comparison of time-restricted feeding and Islamic fasting: a scoping review. East Mediterr Health J. 2019;25(4):239-245.
Bragazzi NL, Briki W, Khabbache H, et al. Ramadan fasting and infectious diseases: a systematic review. J Infect Dev Ctries. 2015;9(11):1186-1194.
Javadi MA, Assadi M, Einollahi B, Rabei HM, Afarid M, Assadi M. The effects of Ramadan fasting on the health and function of the eye. J Res Med Sci. 2014;19(8):786-791.
Fond G, Macgregor A, Leboyer M, Michalsen A. Fasting in mood disorders: neurobiology and effectiveness. A review of the literature. Psychiatry Res. 2013;209(3):253-258.
Bragazzi NL, Briki W, Khabbache H, et al. Ramadan fasting and patients with cancer: state-of-the-art and future prospects. Front Oncol. 2016;6:27.
Almalki MH, Alshahrani F. Options for controlling type 2 diabetes during Ramadan. Front Endocrinol (Lausanne). 2016;7:32.
Bragazzi NL. Ramadan fasting and chronic kidney disease: a systematic review. J Res Med Sci. 2014;19(7):665-676.
Damiani G, Mahroum N, Pigatto PDM, et al. The safety and impact of a model of intermittent, time-restricted circadian fasting ("Ramadan fasting") on Hidradenitis Suppurativa: insights from a multicenter, observational, cross-over, pilot, exploratory study. Nutrients. 2019;11(8):1781.
Adawi M, Damiani G, Bragazzi NL, et al. The impact of intermittent fasting (Ramadan fasting) on psoriatic arthritis disease activity, Enthesitis, and Dactylitis: a multicentre study. Nutrients. 2019;11(3):601.
Damiani G, Watad A, Bridgewood C, et al. The impact of Ramadan fasting on the reduction of PASI score, in moderate-to-severe psoriatic patients: a real-life multicenter study. Nutrients. 2019;11(2):277.
Bragazzi NL, Sellami M, Salem I, et al. Fasting and its impact on skin anatomy, physiology, and physiopathology: a comprehensive review of the literature. Nutrients. 2019;11(2):249.
Rouhani MH, Azadbakht LI. Ramadan fasting related to health outcomes? A review on the related evidence. J Res Med Sci. 2014;19(10):987-992.
Amin MEK, Abdelmageed A, Farhat MJ. Communicating with clinicians on fasting during Ramadan: the patients' perspective. J Relig Health. 2019. https://doi.org/10.1007/s10943-019-00910-x.
Kalra S, Al Deeb A, Sahay R. Ramadan fasting in children. J Pak Med Assoc. 2019;69(5):745-746.
Münch M, Kramer A. Timing matters: new tools for personalized chronomedicine and circadian health. Acta Physiol (Oxf). 2019;227(2):e13300.
Couto Alves A, Glastonbury CA, El-Sayed Moustafa JS, Small KS. Fasting and time of day independently modulate circadian rhythm relevant gene expression in adipose and skin tissue. BMC Genomics. 2018;19(1):659.
GBD 2019 Viewpoint Collaborators. Five insights from the global burden of disease study 2019. Lancet. 2020;396(10258):1135-1159.
GBD 2019 Universal Health Coverage Collaborators. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1250-1284.
GBD 2017 Italy Collaborators. Italy's health performance, 1990-2017: findings from the global burden of disease study 2017. Lancet Public Health. 2019;4(12):e645-e657.
Kunz B, Oranje AP, Labrèze L, Stalder JF, Ring J, Taïeb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European task force on atopic dermatitis. Dermatology. 1997;195(1):10-19.
Hawro T, Ohanyan T, Schoepke N, et al. The Urticaria activity score-validity, reliability, and responsiveness. J Allergy Clin Immunol Pract. 2018;6(4):1185-1190.e1.
Chiang C, Sah D, Cho BK, Ochoa BE, Price VH. Hydroxychloroquine and lichen planopilaris: efficacy and introduction of lichen Planopilaris activity index scoring system. J Am Acad Dermatol. 2010;62(3):387-392.
Micali G, Lacarrubba F, Dall'Oglio F, Tedeschi A, Dirschka T. A new proposed severity score for seborrheic dermatitis of the face: SEborrheic dermatitis area and severity index (SEDASI). J Am Acad Dermatol. 2017;76:AB18.
Foolad N, Prakash N, Shi VY, et al. The use of facial modeling and analysis to objectively quantify facial redness. J Cosmet Dermatol. 2016;15(1):43-48.
Jang YH, Moon SY, Lee WJ, et al. Alopecia Areata progression index, a scoring system for evaluating overall hair loss activity in alopecia Areata patients with pigmented hair: a development and reliability assessment. Dermatology. 2016;232(2):143-149.
Spring P, Gschwind I, Gilliet M. Prurigo nodularis: retrospective study of 13 cases managed with methotrexate. Clin Exp Dermatol. 2014;39(4):468-473.
Heide R, van Doorn K, Mulder PG, et al. Serum tryptase and SCORMA (SCORing MAstocytosis) index as disease severity parameters in childhood and adult cutaneous mastocytosis. Clin Exp Dermatol. 2009;34(4):462-468.
Dunlop WP, Cortina JM, Vaslow JB, Burke MJ. Meta-analysis of experiments with matched groups or repeated measures designs. Psychol Methods. 1996;1:170-177.
Unalacak M, Kara IH, Baltaci D, Erdem O, Bucaktepe PG. Effects of Ramadan fasting on biochemical and hematological parameters and cytokines in healthy and obese individuals. Metab Syndr Relat Disord. 2011;9(2):157-161.
Kocic H, Damiani G, Stamenkovic B, et al. Dietary compounds as potential modulators of microRNA expression in psoriasis. Ther Adv Chronic Dis. 2019;10. https://doi.org/10.1177/2040622319864805.
Damiani G, Bragazzi NL, Garbarino S, et al. Psoriatic and psoriatic arthritis patients with and without jet-lag: does it matter for disease severity scores? Insights and implications from a pilot, prospective study. Chronobiol Int. 2019;36(12):1733-1740.
Okamoto O, Murakami I, Itami S, Takayasu S. Fasting diet therapy for chronic urticaria: report of a case. J Dermatol. 1992;19(7):428-431.
Nakamura H, Shimoji K, Kouda K, Tokunaga R, Takeuchi H. An adult with atopic dermatitis and repeated short-term fasting. J Physiol Anthropol Appl Human Sci. 2003;22(5):237-240.
Lithell H, Bruce A, Gustafsson IB, et al. A fasting and vegetarian diet treatment trial on chronic inflammatory disorders. Acta Derm Venereol. 1983;63(5):397-403.
Damiani G, Conic RRZ, Pigatto PDM, et al. From randomized clinical trials to real life data. An Italian clinical experience with ixekizumab and its management. Dermatol Ther. 2019;32(3):e12886.
Damiani G, Conic RRZ, de Vita V, et al. When IL-17 inhibitors fail: real-life evidence to switch from secukinumab to adalimumab or ustekinumab. Dermatol Ther. 2019;32(2):e12793.
Chiricozzi A, Burlando M, Caldarola G, et al. Ixekizumab effectiveness and safety in the treatment of moderate-to-severe plaque psoriasis: a multicenter, retrospective observational study. Am J Clin Dermatol. 2020 Jun;21(3):441-447.
Paganelli R, Petrarca C, Di Gioacchino M. Biological clocks: their relevance to immune-allergic diseases. Clin Mol Allergy. 2018;16:1.
Smolensky MH, Portaluppi F, Manfredini R, et al. Diurnal and twenty-four hour patterning of human diseases: acute and chronic common and uncommon medical conditions. Sleep Med Rev. 2015;21:12-22.
Hiramoto K, Orita K, Yamate Y, Kasahara E, Yokoyama S, Sato EF. The clock genes are involved in the deterioration of atopic dermatitis after day-and-night reversed physical stress in NC/Nga mice. Open Biochem J. 2018;12:87-102.
Chang YS, Chiang BL. Mechanism of sleep disturbance in children with atopic dermatitis and the role of the circadian rhythm and melatonin. Int J Mol Sci. 2016;17(4):462.
Fishbein AB, Vitaterna O, Haugh IM, et al. Nocturnal eczema: review of sleep and circadian rhythms in children with atopic dermatitis and future research directions. J Allergy Clin Immunol. 2015;136(5):1170-1177.
Vaughn AR, Clark AK, Sivamani RK, Shi VY. Circadian rhythm in atopic dermatitis-pathophysiology and implications for chronotherapy. Pediatr Dermatol. 2018;35(1):152-157.
Ohmori K, Minamide K, Goto S, et al. Time-of-day-dependent variations of scratching behavior and transepidermal water loss in mice that developed atopic dermatitis. J Vet Med Sci. 2014;76(11):1501-1504.
Pacifico A, Damiani G, Iacovelli P, et al. Photoadaptation to ultraviolet B TL01 in psoriatic patients. J Eur Acad Dermatol Venereol. 2020;34(8):1750-1754.
Malerba M, Damiani G, Radaeli A, Ragnoli B, Olivini A, Calzavara-Pinton PG. Narrowband ultraviolet B phototherapy in psoriasis reduces proinflammatory cytokine levels and improves vitiligo and neutrophilic asthma. Br J Dermatol. 2015;173(6):1544-1545.
Damiani G, Radaeli A, Olivini A, Calvara-Pinton P, Malerba M. Increased airway inflammation in patients with psoriasis. Br J Dermatol. 2016;175(4):797-799.
Damiani G, Pacifico A, Rizzi M, et al. Patients with psoriatic arthritis have higher levels of FeNO than those with only psoriasis, which may reflect a higher prevalence of a subclinical respiratory involvement. Clin Rheumatol. 2020;39(10):2981-2988.
Damiani G, Pacifico A, Linder DM, et al. Nanodermatology-based solutions for psoriasis: state-of-the art and future prospects. Dermatol Ther. 2019;32(6):e13113.
Damiani G, Conic RRZ, Pigatto PDM, et al. Predicting Secukinumab fast-responder profile in psoriatic patients: advanced application of artificial-neural-networks (ANNs). J Drugs Dermatol. 2020;19(12):1241-1246.
Asa'ad F, Fiore M, Alfieri A, et al. Saliva as a future field in psoriasis research. Biomed Res Int. 2018;2018:7290913.
Conic RR, Damiani G, Schrom KP, et al. Psoriasis and psoriatic arthritis cardiovascular disease Endotypes identified by red blood cell distribution width and mean platelet volume. J Clin Med. 2020;9(1):186.